Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.

Plentz RR, Park YN, Lechel A, Kim H, Nellessen F, Langkopf BH, Wilkens L, Destro A, Fiamengo B, Manns MP, Roncalli M, Rudolph KL.

Hepatology. 2007 Apr;45(4):968-76.

PMID:
17393506
2.

Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis.

Lee YH, Oh BK, Yoo JE, Yoon SM, Choi J, Kim KS, Park YN.

Mod Pathol. 2009 Aug;22(8):1121-31. doi: 10.1038/modpathol.2009.76. Epub 2009 May 22.

3.

Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence.

Sasaki M, Ikeda H, Yamaguchi J, Nakada S, Nakanuma Y.

Hepatology. 2008 Jul;48(1):186-95. doi: 10.1002/hep.22348.

PMID:
18536059
4.

Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.

Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M.

Hepatology. 1999 Jul;30(1):90-9.

PMID:
10385644
6.

Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.

Plentz RR, Caselitz M, Bleck JS, Gebel M, Flemming P, Kubicka S, Manns MP, Rudolph KL.

Hepatology. 2004 Jul;40(1):80-6.

PMID:
15239089
7.

Large liver cell change in hepatitis B virus-related liver cirrhosis.

Kim H, Oh BK, Roncalli M, Park C, Yoon SM, Yoo JE, Park YN.

Hepatology. 2009 Sep;50(3):752-62. doi: 10.1002/hep.23072.

PMID:
19585549
8.

Increased expression of stathmin and elongation factor 1α in precancerous nodules with telomere dysfunction in hepatitis B viral cirrhotic patients.

Ahn EY, Yoo JE, Rhee H, Kim MS, Choi J, Ko JE, Lee JS, Park YN.

J Transl Med. 2014 May 31;12:154. doi: 10.1186/1479-5876-12-154.

9.
10.

High expression of p21WAF1/CIP1 is correlated with human hepatocellular carcinoma in patients with hepatitis C virus-associated chronic liver diseases.

Wagayama H, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Yamanaka T, Takase K, Nakano T.

Hum Pathol. 2002 Apr;33(4):429-34.

PMID:
12055678
11.

Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.

Lechel A, Holstege H, Begus Y, Schienke A, Kamino K, Lehmann U, Kubicka S, Schirmacher P, Jonkers J, Rudolph KL.

Gastroenterology. 2007 Apr;132(4):1465-75. Epub 2007 Jan 26.

PMID:
17433324
12.
13.

Cause-specific telomere factors deregulation in hepatocellular carcinoma.

El Idrissi M, Hervieu V, Merle P, Mortreux F, Wattel E.

J Exp Clin Cancer Res. 2013 Sep 11;32:64. doi: 10.1186/1756-9966-32-64.

15.

The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.

Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE.

Am J Surg Pathol. 2007 May;31(5):681-9.

PMID:
17460450
16.

Cell cycle regulators in bladder cancer: relationship to schistosomiasis.

Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O.

IUBMB Life. 2004 Sep;56(9):557-64.

17.

Correlation of telomere length shortening with promoter methylation profile of p16/Rb and p53/p21 pathways in breast cancer.

Radpour R, Barekati Z, Haghighi MM, Kohler C, Asadollahi R, Torbati PM, Holzgreve W, Zhong XY.

Mod Pathol. 2010 May;23(5):763-72. doi: 10.1038/modpathol.2009.195. Epub 2010 Jan 15.

18.

Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.

Oh BK, Jo Chae K, Park C, Kim K, Jung Lee W, Han KH, Nyun Park Y.

J Hepatol. 2003 Nov;39(5):786-92.

PMID:
14568262
19.

Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.

Azechi H, Nishida N, Fukuda Y, Nishimura T, Minata M, Katsuma H, Kuno M, Ito T, Komeda T, Kita R, Takahashi R, Nakao K.

Oncology. 2001;60(4):346-54.

PMID:
11408803
20.

p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis.

Matsuda Y, Ichida T.

Med Mol Morphol. 2006 Dec;39(4):169-75. Epub 2006 Dec 21. Review.

PMID:
17187177

Supplemental Content

Support Center